Yakult Honsha Co Ltd
TSE:2267
Yakult Honsha Co Ltd
Net Issuance of Common Stock
Yakult Honsha Co Ltd
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Yakult Honsha Co Ltd
TSE:2267
|
Net Issuance of Common Stock
-¥29.4B
|
CAGR 3-Years
-2 349%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ajinomoto Co Inc
TSE:2802
|
Net Issuance of Common Stock
-¥120B
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-625%
|
CAGR 10-Years
-15%
|
|
|
Meiji Holdings Co Ltd
TSE:2269
|
Net Issuance of Common Stock
-¥30B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-67%
|
|
|
Kikkoman Corp
TSE:2801
|
Net Issuance of Common Stock
-¥9.7B
|
CAGR 3-Years
-57%
|
CAGR 5-Years
-260%
|
CAGR 10-Years
0%
|
|
|
Nissin Foods Holdings Co Ltd
TSE:2897
|
Net Issuance of Common Stock
-¥31.7B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-439%
|
CAGR 10-Years
-126%
|
|
|
Toyo Suisan Kaisha Ltd
TSE:2875
|
Net Issuance of Common Stock
-¥23.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-22%
|
|
Yakult Honsha Co Ltd
Glance View
Yakult Honsha Co., Ltd., a company rooted in Japanese tradition and scientific innovation, has become a global powerhouse in the probiotics industry. The journey began in 1935 when microbiologist Minoru Shirota pioneered the development of a fermented milk drink containing a unique strain of bacteria, Lactobacillus casei Shirota. This visionary endeavor aimed to improve gut health utilizing the principles of preventive medicine, a novel concept at the time. Yakult's flagship product, a small, iconic bottle of sweet-tasting probiotic milk, swiftly captured the attention and trust of Japanese consumers, setting the company on a trajectory of continuous growth and worldwide expansion. The company leveraged its strong research foundation to consistently innovate its product offerings, ensuring Yakult remained at the forefront of the health and wellness trend. In the modern marketplace, Yakult's operations exemplify a successful case of strategic internationalization. By maintaining a robust distribution network across more than 40 countries, the company effectively taps into varying health consciousness trends across diverse cultures. Revenue is primarily derived from the sales of its probiotic beverages, which are produced through a time-honored fermentation process. Yakult has strengthened its market position through direct sales strategies, including the hallmark “Yakult Ladies,” who personally deliver products to customers, enhancing consumer engagement and fostering brand loyalty. Beyond beverages, Yakult has diversified its portfolio to include cosmetics and pharmaceuticals, though the probiotic drinks remain its core profit engine. This diversification not only draws on the company's microbiological expertise but also mitigates risk by reducing dependency on a single product line.
See Also
What is Yakult Honsha Co Ltd's Net Issuance of Common Stock?
Net Issuance of Common Stock
-29.4B
JPY
Based on the financial report for Dec 31, 2024, Yakult Honsha Co Ltd's Net Issuance of Common Stock amounts to -29.4B JPY.
What is Yakult Honsha Co Ltd's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 3Y
-2 349%
The average annual Net Issuance of Common Stock growth rates for Yakult Honsha Co Ltd have been -2 349% over the past three years .
You don't have any saved screeners yet